Spectrum of Bone Marrow Failures of Myeloid Series: New Report of Neutropenic Patients from a Referral Pediatric Center in Iran

REFERENCES

• Rezaei N, Farhoudi A, Ramyar A, Congenital neutropenia and primary immunodeficiency disorders: a survey of 26 Iranian patients. J Pediatr Hematol Oncol. 2005;27:351–356.
   Google Scholar
• Rezaei N, Moazzami K, Aghamohammadi A, Neutropenia and primary immunodeficiency diseases. Int Rev Immunol. 2009;28:335–366.
   PubMed Web of Science ®Google Scholar
• Donadieu J, Fenneteau O, Beaupain B, Congenital neutropenia: diagnosis, molecular bases and patient management. Orphanet J Rare Dis. 2011;6:1–28.
   Google Scholar
• Ward AC, Dale DC. Genetic and molecular diagnosis of severe congenital neutropenia. Curr Opin Hematol. 2009;16:9–13.
   PubMed Web of Science ®Google Scholar
• Boztug K, Appaswamy G, Ashikov A, A syndrome with congenital neutropenia and mutations in G6PC3. N Engl J Med. 2009;360:32–43.
   PubMed Web of Science ®Google Scholar
• Germeshausen M, Grudzien M, Zeidler C, Novel HAX1 mutations in patients with severe congenital neutropenia reveal isoform-dependent genotype-phenotype associations. Blood. 2008;111:4954–4957.
   PubMed Web of Science ®Google Scholar
• Klein C, Grudzien M, Appaswamy G, HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat Genet. 2007;39:86–92.
   PubMed Web of Science ®Google Scholar
• Salipante SJ, Benson KF, Luty J, Double de novo mutations of ELA2 in cyclic and severe congenital neutropenia. Hum Mutat. 2007;28:874–881.
   PubMedGoogle Scholar
• Etzioni A. Novel aspects of phagocytic cell disorders. Curr Opin Allergy Clin Immunol. 2001;1:535–540.
   Google Scholar
• Rezaei N, Farhoudi A, Pourpak Z, Neutropenia in Iranian patients with primary immunodeficiency disorders. Haematologica. 2005;90:554–556.
   PubMedGoogle Scholar
• Rezaei N, Aghamohammadi A, Moin M, Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian Primary Immunodeficiency Registry. J Clin Immunol. 2006;26:519–532.
   PubMed Web of Science ®Google Scholar
• Rezaei N, Moin M, Pourpak Z, The clinical, immunohematological, and molecular study of Iranian patients with severe congenital neutropenia. J Clin Immunol. 2007;27:525–533.
   Google Scholar
• Rezaei N, Pourpak Z, Aghamohammadi A, Consanguinity in primary immunodeficiency disorders; the report from Iranian Primary Immunodeficiency Registry. Am J Reprod Immunol. 2006;56:145–151.
   PubMed Web of Science ®Google Scholar
• Boxer LA. How to approach neutropenia. Hematology Am Soc Hematol Educ Program. 2012;2012:174–182.
   PubMedGoogle Scholar
• Mamishi S, Esfahani SA, Parvaneh N, Severe congenital neutropenia in 2 siblings of consanguineous parents. The role of HAX1 deficiency. J Investig Allergol Clin Immunol. 2009;19:500–503.
   Google Scholar
• Malcov M, Reches A, Ben-Yosef D, Resolving a genetic paradox throughout preimplantation genetic diagnosis for autosomal dominant severe congenital neutropenia. Prenat Diagn. 2010;30:207–211.
   Google Scholar
• Aghamohammadi A, Fiorini M, Moin M, Clinical, immunological and molecular characteristics of 37 Iranian patients with X-linked agammaglobulinemia. Int Arch Allergy Immunol. 2006;141:408–414.
   PubMed Web of Science ®Google Scholar
• Moin M, Aghamohammadi A, Farhoudi A, X-linked agammaglobulinemia: a survey of 33 Iranian patients. Immunol Invest. 2004;33:81–93.
   PubMed Web of Science ®Google Scholar
• Aghamohammadi A, Parvaneh N, Rezaei N, Clinical and laboratory findings in hyper-IgM syndrome with novel CD40L and AICDA mutations. J Clin Immunol. 2009;29:769–776.
   PubMed Web of Science ®Google Scholar
• Rezaei N, Aghamohammadi A, Ramyar A, Severe congenital neutropenia or hyper-IgM syndrome? A novel mutation of CD40 ligand in a patient with severe neutropenia. Int Arch Allergy Immunol. 2008;147:255–259.
   PubMed Web of Science ®Google Scholar
• Lekstrom-Himes JA, Gallin JI. Immunodeficiency diseases caused by defects in phagocytes. N Engl J Med. 2000;343:1703–1714.
   PubMed Web of Science ®Google Scholar
• Cham B, Bonilla MA, Winkelstein J. Neutropenia associated with primary immunodeficiency syndromes. Semin Hematol. 2002;39:107–112.
   PubMed Web of Science ®Google Scholar
• Tokumi T, Ohnishi H, Kaneko H, [Primary immunodeficiency diseases caused by defects in innate immunity: update]. Arerugi. 2009;58:19–28.
   Google Scholar
• Rackoff WR, Gonin R, Robinson C, Predicting the risk of bacteremia in childen with fever and neutropenia. J Clin Oncol. 1996;14:919–924.
   PubMed Web of Science ®Google Scholar
• Wintergerst U, Rosenzweig SD, Abinun M, Phagocytes defects. In: Rezaei N, Aghamohammadi A, Notarangelo LD, eds. Primary Immunodeficiency Diseases: Definition, Diagnosis and Management. Heidelberg: Springer-Verlag; 2008:131–166.
   Google Scholar
• Gurwith MJ, Brunton JL, Lank BA, A prospective controlled investigation of prophylactic trimethoprim/sulfamethoxazole in hospitalized granulocytopenic patients. Am J Med. 1979;66:248–256.
   PubMed Web of Science ®Google Scholar
• Carlsson G, Ahlin A, Dahllof G, Efficacy and safety of two different rG-CSF preparations in the treatment of patients with severe congenital neutropenia. Br J Haematol. 2004;126:127–132.
   PubMed Web of Science ®Google Scholar
• Donadieu J, Boutard P, Bernatowska E, A European phase II study of recombinant human granulocyte colony-stimulating factor (lenograstim) in the treatment of severe chronic neutropenia in children. Lenograstim Study Group. Eur J Pediatr. 1997;156:693–700.
   PubMed Web of Science ®Google Scholar